"Adding value to the business we serve."

Health sciences & care, pharmaceuticals & biotech

Date : 4/8/2022

Health sciences & care, pharmaceuticals & biotech

While fiscal restraint across the world is creating significant challenges for health care providers, demographic changes and scientific advances also bring tremendous opportunities.

With the global population set to reach 8 billion by 2025, growing levels of lifestyle-related chronic diseases and advances in medical technology, are forcing an unprecedented pace of change.

Experts from UHY member firms have a thorough understanding of the health sector and work with a wide range of organizations from public healthcare providers to international pharmaceutical companies.

They provide a comprehensive range of services from regulatory and compliance management to advice on protecting intellectual property rights – an issue that is particularly relevant for clients in the pharmaceutical and medical device development sector.


While health care systems are typically organized on national levels, they face common challenges and opportunities as reform drives the need for greater efficiency in the face of tighter budgets, increased patient expectations, and changing regulations.

The global nature of the UHY network means clients can benefit from insight into the development of best practices across the world along with expertise on key issues such as pricing pressures and complex regulatory requirements


  • Financial and operational (cost reports and financial/operational analysis, negotiations/receivership services, rate reimbursement, and appeals)
  • IT/technology (enterprise risk management and vulnerability assessments)
  • Litigation/fraud-related services
  • Auditing
  • Financial statement reviews and compilations
  • Sarbanes-Oxley/corporate governance planning & compliance (for best practices)
  • Managed care consulting (contract analysis and negotiation, cost analysis, network and alliance development)
  • Strategic planning